AI-generated from publicly available materials.Three innovative medtech startups from South India have emerged victorious in the HealthSprint 2026 initiative, a collaboration between Israel and GINSERV, securing a fully funded week-long program in Israel to explore global healthcare opportunities.
The winning startups—BioCipher Labs, Prodancy, and Mykare.ai—each bring unique solutions to the healthcare sector. BioCipher Labs focuses on AI-driven molecular diagnostics, Prodancy has created a surgical helmet for joint replacements to reduce dependency on imported products, and Mykare.ai offers an AI-based patient management platform tailored for clinics and smaller hospitals. This initiative aims to facilitate their entry into international markets by immersing them in Israel's advanced healthcare ecosystem.
HealthSprint 2026 attracted 175 applications, with a competitive selection process narrowing it down to 15 finalists, who pitched their ideas to industry experts and investors. The program's significance was highlighted by Max Shmagin, deputy consul general for the Consulate General of Israel in Bengaluru, who noted the potential for India-Israel collaboration to enhance clinical validation and scalability of healthcare solutions.
The involvement of seasoned mentors and investors, such as representatives from Sheba Medical Centre and eHealth Ventures, underscores the program's focus on practical learning and adaptability. This initiative not only fosters innovation but also emphasizes the importance of affordability and accessibility in healthcare, as articulated by Dr. CN Manjunath. The collaboration signals a promising future for medtech startups looking to expand their reach and impact globally.